|
⚲
|
| Keyboard |
| 5AM Partners VII LLC
✚
|
|
|---|---|
| CIK # | 0001873545 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001873545] | |
| 4 | [0001873545] | |
| SC 13D | [0001873545] | |
| SC 13G | [0001873545] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| 5AM Partners VII LLC | Surrozen Inc/DE | [2025-04-02] |
| 5AM Partners VII LLC | Dianthus Therapeutics Inc /DE/ | [2023-09-21] |
| 5AM Partners VII LLC | Skye Bioscience Inc | [2023-08-28] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| 5AM Partners II LLC | |
| 5AM Partners VII LLC | |
| 5AM Ventures VII LP | |
| Parmar Kush | |
| 5AM Ventures II LP | |
| Rocklage Scott M | |
| Diekman John D | |
| Skye Bioscience Inc | |
| 5AM Co-Investors II LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Skye Bioscience Inc SKYE
Common Stock
|
2024-09-13 | Sell | 11,758 | $6.06 | 71,253 |
|
Skye Bioscience Inc SKYE
Common Stock
|
2024-09-13 | Sell | 2,000 | $6.06 | 12,120 |
|
Skye Bioscience Inc SKYE
Common Stock
|
2024-09-13 | Sell | 79 | $6.06 | 479 |
|
Skye Bioscience Inc SKYE
Common Stock
|
2024-09-11 | Sell | 214,556 | $6.60 | 1,416,070 |
|
Skye Bioscience Inc SKYE
Common Stock
|
2024-09-11 | Sell | 1,440 | $6.60 | 9,504 |
|
Skye Bioscience Inc SKYE
Common Stock
|
2024-09-11 | Sell | 36,504 | $6.60 | 240,926 |
|
Skye Bioscience Inc SKYE
Common Stock
|
2024-03-13 | Buy | 450,000 | $10.00 | 4,500,000 |
|
Skye Bioscience Inc SKYE
Common Stock
|
2024-01-31 | Buy | 5,206,074 | $2.31 | 12,026,031 |